| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" encoding="windows-1252"?> |
<notificationOfRemoval> |
| <schemaVersion> X0203 </schemaVersion> |
| <exchange> |
| | <cik> 0001354457 </cik> |
| | <entityName> Nasdaq Stock Market LLC </entityName> |
| | </exchange> |
| <issuer> |
| | <cik> 0001270073 </cik> |
| | <entityName> INTERCEPT PHARMACEUTICALS, INC. </entityName> |
| | <fileNumber> 001-35668 </fileNumber> |
| | <address> |
| | | <street1> 18 Desbrosses Street </street1> |
| | | <street2></street2> |
| | | <city> New York </city> |
| | | <stateOrCountryCode> NY </stateOrCountryCode> |
| | | <stateOrCountry> NEW YORK </stateOrCountry> |
| | | <zipCode> 10013 </zipCode> |
| | | </address> |
| | <telephoneNumber> 646-747-1000 </telephoneNumber> |
| | </issuer> |
| <descriptionClassSecurity> Common Stock </descriptionClassSecurity> |
| <ruleProvision> 17 CFR 240.12d2-2(a)(3) </ruleProvision> |
| <signatureData> |
| | <signatureName> Tara Petta </signatureName> |
| | <signatureTitle> AVP </signatureTitle> |
| | <signatureDate> 2023-11-08 </signatureDate> |
| | </signatureData> |
| </notificationOfRemoval> |